224 research outputs found

    Palaeoenvironmental analysis of the Miocene barnacle facies: case studies from Europe and South America

    Get PDF
    Acorn barnacles are sessile crustaceans common in shallow-water settings, both in modern oceans and in the Miocene geological record. Barnacle-rich facies occur from polar to equatorial latitudes, generally associated with shallow-water, high-energy, hard substrates. The aim of this work is to investigate this type of facies by analysing, from the palaeontological, sedimentological and petrographical points of view, early Miocene examples from Northern Italy, Southern France and South-western Peru. Our results are then compared with the existing information on both modern and fossil barnacle-rich deposits. The studied facies can be divided into two groups. The first one consists of very shallow, nearshore assemblages where barnacles are associated with an abundant hard-substrate biota (e.g., barnamol). The second one includes a barnacle-coralline algae association, here named “barnalgal” (= barnacle / red algal dominated), related to a deeper setting. The same pattern occurs in the distribution of both fossil and recent barnacle facies. The majority of them are related to very shallow, high-energy, hard-substrate, a setting that represents the environmental optimum for the development of barnacle facies, but exceptions do occur. These atypical facies can be identified through a complete analysis of both the skeletal assemblage and the barnacle association, showing that barnacle palaeontology can be a powerful tool for palaeoenvironmental reconstruction

    Disentangling thermal and nonthermal excited states in a charge-transfer insulator by time- and frequency-resolved pump-probe spectroscopy

    Get PDF
    Time- and frequency-resolved pump-probe optical spectroscopy is used to investigate the effects of the impulsive injection of delocalized excitations through a charge-transfer process in insulating CuGeO3. A large broadening of the charge-transfer edge is observed on the sub-ps time scale. The modification of this spectral feature cannot be attributed to the local increase in the effective temperature, as a consequence of the energy absorbed by the pump pulse. The measured modifications of the optical properties of the system are consistent with the creation of a nonthermal state, metastable on the picosecond time scale, after the pump-induced impulsive modification of the electron interactions

    Palaeoenvironmental analysis of the Miocene barnacle facies: Case studies from Europe and South America

    Get PDF
    Acorn barnacles are sessile crustaceans common in shallow-water settings, both in modern oceans and in the Miocene geological record. Barnacle-rich facies occur from polar to equatorial latitudes, generally associated with shallow-water, high-energy, hard substrates. The aim of this work is to investigate this type of facies by analysing, from the palaeontological, sedimentological and petrographical points of view, early Miocene examples from Northern Italy, Southern France and South-western Peru. Our results are then compared with the existing information on both modern and fossil barnacle-rich deposits. The studied facies can be divided into two groups. The first one consists of very shallow, nearshore assemblages where barnacles are associated with an abundant hard-substrate biota (e.g., barnamol). The second one includes a barnacle-coralline algae association, here named "barnalgal" (=barnacle/red algal dominated), related to a deeper setting. The same pattern occurs in the distribution of both fossil and recent barnacle facies. The majority of them are related to very shallow, high-energy, hard-substrate, a setting that represents the environmental optimum for the development of barnacle facies, but exceptions do occur. These atypical facies can be identified through a complete analysis of both the skeletal assemblage and the barnacle association, showing that barnacle palaeontology can be a powerful tool for palaeoenvironmental reconstruction

    The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

    Get PDF
    Background: In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic factor. The purpose of this retrospective study was to investigate if somatic mutations could represent an additional prognostic value in respect of MRD alone. Method: At baseline, 98 patients were tested for NPM1, FLT3, and for WT1 expression; 31 for ASXL1, TET2, IDH1, IDH2, N-RAS, WT1, c-KIT, RUNX1, and DNMT3A. The same genes have been also tested after induction and consolidation. Results: Overall, 60.2% of our patients resulted mutated: 24.5% carried mutations of FLT3-ITD, 38.7% of NPM1, 48.4% of c-KIT, 25.8% of N-RAS and 19.3% of IDH2. The probability of achieving a complete response (CR) was higher for younger patients, with low ELN risk score, NPM1-mutated, with low WT1 levels, and without FLT3. The presence of additional mutations represented a poor predictive factor: only 19% of these cases achieved CR in comparison to 43% of subjects without any of it. Concerning survival, it was conditioned by a lower ELN risk score, younger age, reduction > 1 log of the NPM1 mutational burden, disappearance of FLT3 mutations and lower WT1 expression. Regarding the role of the additional mutations, they impaired the outcome of 20% of the already MRD-negative patients. Concerning the possibility of predicting relapse, we observed an increase of the NPM1 mutational burden at the time-point immediately preceding the relapse (about 2 months earlier) in 50% of subjects. Similarly concerning WT1, an increase of its expression anticipated disease recurrence in 64% of cases. Conclusions: We demonstrated that additional somatic mutations are able to impair outcome of the already MRD-negative subjects. About MRD, we suggest a prognostic role also for the WT1 expression. Finally, we considered as relevant the assessment of NPM1 quantity clearance instead of the presence/absence of mutations alone. Still remains in doubt the utility in terms of long-term prognosis of a baseline more complex mutational screening; we could hypothesize that it would be useful for those patients where other markers are not available or who reached the MRD negativity

    p-Adic Mathematical Physics

    Full text link
    A brief review of some selected topics in p-adic mathematical physics is presented.Comment: 36 page

    Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Get PDF
    OBJECTIVES: To analyse the frequency and characterise the systemic presentation of primary Sjögren’s syndrome (SS) out of the ESSDAI classification in a large international, multi-ethnic cohort of patients. // METHODS: The Big Data Sjögren Project Consortium is an international, multicentre registry based on world-wide data-sharing and cooperative merging of pre-existing clinical SS databases from leading centres in clinical research in SS from the five continents. A list of 26 organ-by-organ systemic features not currently included in the ESSDAI classification was defined according to previous studies; these features were retrospectively recorded. // RESULTS: Information about non-ESSDAI features was available in 6331 patients [5,917 female, mean age at diagnosis 52 years, mainly White (86.3%)]. A total of 1641 (26%) patients had at least one of the ESSDAI systemic features. Cardiovascular manifestations were the most frequent organ-specific group of non-ESSDAI features reported in our patients (17% of the total cohort), with Raynaud’s phenomenon being reported in 15%. Patients with systemic disease due to non-ESSDAI features had a lower frequency of dry mouth (90.7% vs. 94.1%, p<0.001) and positive minor salivary gland biopsy (86.7% vs. 89%, p=0.033), a higher frequency of anti-Ro/SSA (74.7% vs. 68.7%, p<0.001), anti-La/SSB antibodies (44.5% vs. 40.4%, p=0.004), ANA (82.7% vs. 79.5%, p=0.006), low C3 levels (17.4% vs. 9.7%, p<0.001), low C4 levels (14.4% vs. 9.6%, p<0.001), and positive serum cryoglobulins (8.6% vs. 5.5%, p=0.001). Systemic activity measured by the ESSDAI, clinESSDAI and DAS was higher in patients with systemic disease out of the ESSDAI in comparison with those without these features (p<0.001 for all comparisons). // CONCLUSIONS: More than a quarter of patients with primary SS may have systemic manifestations not currently included in the ESSDAI classification, with a wide variety of cardiovascular, digestive, pulmonary, neurological, ocular, ENT (ear, nose, and throat), cutaneous and urological features that increase the scope of the systemic phenotype of the disease. However, the individual frequency of each of these non-ESSDAI features was very low, except for Raynaud’s phenomenon

    Mortality risk factors in primary Sjögren syndrome:a real-world, retrospective, cohort study

    Get PDF
    BACKGROUND: What baseline predictors would be involved in mortality in people with primary Sjögren syndrome (SjS) remains uncertain. This study aimed to investigate the baseline characteristics collected at the time of diagnosis of SjS associated with mortality and to identify mortality risk factors for all-cause death and deaths related to systemic SjS activity measured by the ESSDAI score.METHODS: In this international, real-world, retrospective, cohort study, we retrospectively collected data from 27 countries on mortality and causes of death from the Big Data Sjögren Registry. Inclusion criteria consisted of fulfilling 2002/2016 SjS classification criteria, and exclusion criteria included chronic HCV/HIV infections and associated systemic autoimmune diseases. A statistical approach based on a directed acyclic graph was used, with all-cause and Sjögren-related mortality as primary endpoints. The key determinants that defined the disease phenotype at diagnosis (glandular, systemic, and immunological) were analysed as independent variables.FINDINGS: Between January 1st, 2014 and December 31, 2023, data from 11,372 patients with primary SjS (93.5% women, 78.4% classified as White, mean age at diagnosis of 51.1 years) included in the Registry were analysed. 876 (7.7%) deaths were recorded after a mean follow-up of 8.6 years (SD 7.12). Univariate analysis of prognostic factors for all-cause death identified eight Sjögren-related variables (ocular and oral tests, salivary biopsy, ESSDAI, ANA, anti-Ro, anti-La, and cryoglobulins). The multivariate CPH model adjusted for these variables and the epidemiological features showed that DAS-ESSDAI (high vs no high: HR = 1.68; 95% CI, 1.27-2.22) and cryoglobulins (positive vs negative: HR = 1.72; 95% CI, 1.22-2.42) were independent predictors of all-cause death. Of the 640 deaths with available information detailing the specific cause of death, 14% were due to systemic SjS. Univariate analysis of prognostic factors for Sjögren-cause death identified five Sjögren-related variables (oral tests, clinESSDAI, DAS-ESSDAI, ANA, and cryoglobulins). The multivariate competing risks CPH model adjusted for these variables and the epidemiological features showed that oral tests (abnormal vs normal results: HR = 1.38; 95% CI, 1.01-1.87), DAS-ESSDAI (high vs no high: HR = 1.55; 95% CI, 1.22-1.96) and cryoglobulins (positive vs negative: HR = 1.52; 95% CI, 1.16-2) were independent predictors of SjS-related death.INTERPRETATION: The key mortality risk factors at the time of SjS diagnosis were positive cryoglobulins and a high systemic activity scored using the ESSDAI, conferring a 2-times increased risk of all-cause and SjS-related death. ESSDAI measurement and cryoglobulin testing should be considered mandatory when an individual is diagnosed with SjS.FUNDING: Novartis.</p
    • …
    corecore